While expression levels of anti-apoptotic Bcl-2 remained unchanged upon incubation with betulinic acid in neuroblastoma and squamous cell carcinoma cells, an increase in Bcl-2 protein levels was reported in glioblastoma cells [12, 14, 18]. The gene discussed is BCL2; the disease is neuroblastoma.